Open menu

Tandem

The Tandem t:slim X2

Tandem G6 2019

Pump Features 

  • Colour touch screen
  • Dexcom G6 CGM enabled 
  • Rechargable battery
  • Tubed proprietary infusion sets
  • Upgrades are done via software downloads after learning module completions.
  • Basal IQ, the feature in older models, only reduces basal insulin but also allows for individualization of glucose targets e.g. in pregnancy. Tandem provides loaners for clients on Control IQ currently wishing to transfer to Basal IQ during their pregnancy. 
  • Control-IQ is in the newest upgrade. It adjusts insulin delivery to help prevent highs (automated partial corrections and increased basal insulin) and lows (temp basal suspensions), while requiring the user to manually bolus for meals. Individualization of glucose targets is not an option. The algorithm uses a patient's programmed basal rates, and correction factors (ISF) and potentially other factors to make automated dose adjustments. Carbohydrate counting and food boluses are still required. When Control IQ is active, a patient can adjust basal rates, ISF, carb ratios but not insulin duration, and not glucose targets. 

How Control IQ Works

Tandem Contol IQ ActionsChart2021

 

Training

 

 

Time-Limited Clinician Education (time zone Eastern)

Getting the Most Out of Control-IQ™Technology: Case Reviews
A“mini-series” of weekly, quick-learning, advanced case reviews (sleep, exercise, complex meals, gastroparesis, challenging situations, etc.) for health care professionals. Join us when you can to review a new case each week. Register in advance for these meetings:

12:05 – 12:30 PM ET Wednesdays May 12th to June 23rd, 2021 https://tandemdiabetes.zoom.us/meeting/register/tJcldOGoqj0tHdHYWSxExAX6mTkCtdoyCxPU

3:00-3:30 PM ET Thursdays May 13th to June 24th, 2021 https://tandemdiabetes.zoom.us/meeting/register/tJIqcuyrrD0sHdPl9eJngnQGxZlwoYYnPmfz

Notes for Dose Adjustments & FYI

Indications, TDD, Weight & other FYI

  • TDD and weight Indications for Control IQ are TDD 10-100 units per day and weight  25-140 kg. Patients beyond these indication levels have still used Control IQ; it is then an off-label usage.  These are the maximum allowable entries into the system at initiation.Control-IQ uses these initial entries to enable the algorithm to start working right immediately without awaiting past data for the algorithm. However, as time passes, the algorithm uses actual delivered TDD based on a rolling 6 day average. 
  • Max Basal Rate:
    If programmed basal rate is > 3u/hr, the system will deliver it if the CGM signal is active. However, for safety, if a CGM signal is lost for > 20 minutes the system reverts to 3u/hr as max even if their programmed rate is >3u/hr. To avoid this being an issue, suggest having the patient turn Control-IQ OFF during the two hour warm up on a new sensor every 10 days.
  • For basal modulations and automated corrections in Control IQ, the algorithm requires the following.
    • Programmed basal rates
    • Programmed correction factor (ISF)
    • The last 6 days of total daily insulin dose or the inputted total daily dose and weight at the start of using Control IQ. It’s recommended, but not required, to update these values on occasion. These should be updated to current values if resuming pump after having been off it.
      Current and predicted glucose reading 30 minutes out
    • Glucose target (default, sleep or exercise)
    • Insulin on board
  • Bolus information
    • Maximum bolus size is 25u. Over that, patients would need two boluses for a meal.
    • Max extended bolus duration is 2 hours.
    • Control IQ suggests manual meal boluse and manual corrections doses using the same calculations of the pump in manual mode.

Hypoglycemia:

  • Prioritize your problem solving and change doses for actual hypoglycemia events that occur despite Control IQ suspending low.
  • Frequent basal suspensions in the reports (red bars) do not necessarily indicate hypoglycemia or indicate a need for a change in therapy. Problem solve or change doses if the suspensions are for longer periods of time and/or with a regular pattern. Tandem indicates short suspensions are 5-30 minutes. Long suspensions are more than 30-45 minutes. 
  • Tandem suggests using 5-10 g or rapid acting carbohydrate to treat hypoglycemia and evaluate. Since basal insulin delivery had already been suspended for some period of time, the full carbohydrate treatment may not be needed.

Hyperglycemia:

  • Frequent auto basal increases or hourly auto corrections in the Diasend reports do not necessarily indicate a need for change in therapy. 
  • Assess problem areas of high readings  where the automated insulin delivery cannot address the hyperglycemia. 
  • The Tandem user guide reports the maximum insulin delivery rate is calculated using ISF (Insulin Sensitivity Factor or Correction Factor), estimated and recorded total daily insulin, and IOB (current insulin on board).
  • Hyperglycemia occuring in repeated patterns may be addressed with basal rate changes or depending on the timing, ICR. 
  • Hyperglycemia that is frequent but sporadic in timing and non responsive may, after troubleshooting, be addressed with changes to ISF.  Tandem uses an insulin action time of 5 hours. Some patients have found they need a more agressive ISF when in Control IQ. 
  • Patients may wish to set different basal profiles: A manual profile with usual (less agressive) ISF when not using Control IQ; A profile for when control IQ is used on a usual day (may have a more aggressive ISF); A profile for when sick or menstruating which may have increased basal rates beyond the settings used for their usual Control IQ profile. 

 

Company Contacts & "Office Hours" for HCP Questions

  • Tandem Diabetes Care Canada Website
  • Territory Manager Kate Stephen This email address is being protected from spambots. You need JavaScript enabled to view it.
  • PHONE: (403) 512-2632 FAX: (858) 224-6400

"Office Hours" for Healthcare Professionals ONLY to connect with Tandem Trainers are below: